Ocugen, Inc. (OCGN) Financials

OCGN Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 124.2 million 140.8 million
March 31, 2026 56.9 million 51.1 million
Dec. 31, 2025 44.3 million 56.5 million
Sept. 30, 2025 57.6 million 54.1 million

OCGN Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -12.6 million 1.8 million
March 31, 2026 -21.8 million 3.4 million
Dec. 31, 2025 -14.0 million 2.0 million
Sept. 30, 2025 -13.0 million 2.0 million

OCGN Net Income

No data available :(

OCGN Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 100.1 million 1.7 million 3.9 million
March 31, 2026 31.9 million 24.2 million 4.1 million
Dec. 31, 2025 18.6 million 27.5 million 4.4 million
Sept. 30, 2025 32.6 million 28.4 million 4.6 million

OCGN Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 338.7 million
March 31, 2026 320.4 million
Dec. 31, 2025 312.3 million
Sept. 30, 2025 304.0 million

OCGN Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 21000 10.7 million 7.2 million -
March 31, 2026 6000 11.3 million 8.1 million -
Dec. 31, 2025 35000 10.7 million 6.1 million -
Sept. 30, 2025 91000 11.1 million 8.2 million -

OCGN Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.5 million -
March 31, 2026 1.5 million -
Dec. 31, 2025 -193000 -
Sept. 30, 2025 1.8 million -

OCGN

Price: $1.38

52 week price:
0.93
2.73

Earnings Per Share: -0.27 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 4.7 million

Market Capitalization: 474.8 million

Links: